New 16 hour ADHD med approved

“Shire wins U.S. approval for long-acting ADHD drug” by Natalie Grover, Ben Hirschler of Reuters

Shire received approval for a new long-acting medication named Mydayis. It is the same as Adderall XR (i.e., amphetamine & dextroamphetamine mixed salts) but should last 16 hours, compared to Adderall XR’s 12 hours. Read more here.

Share
This entry was posted in ADHD, medication, Stories. Bookmark the permalink.